Mood stabilizers in child and adolescent;Les thymoregulateurs chez l'enfant et l'adolescent

Neuropsychiatrie de l'Enfance et de l'Adolescence

Volumn 60, Issue 1, 2012, Pages 5-11

  Gramond, A ^a   Consoli, A ^b   Maury, M ^a   Purper Ouakil, D ^c,d  

^a HÔPITAL SAINT ELOI   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d INSERM   (France)

Author keywords

Adolescent; Antipsychotics; Bipolar disorder; Child; Clinical trials; Mood stabilizers

Indexed keywords

ARIPIPRAZOLE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; CHILD; CHILD PSYCHIATRY; DRUG EFFICACY; DRUG INDICATION; DRUG UTILIZATION; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH CARE; METHODOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE;

EID: 84856776263     PISSN: 02229617     EISSN: 17696615     Source Type: Journal    
DOI: 10.1016/j.neurenf.2011.08.001     Document Type: Article

References (49)

1. Lewinsohn P.M., Klein D.N., Seeley J.R. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995, 34(4):454-463.
2. Kim-Cohen J., Caspi A., Moffitt T.E., Harrington H., Milne B.J., Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 2003, 60(7):709-717.
3. Carlson G.A. Early onset bipolar disorder: clinical and research considerations. J Clin Child Adolesc Psychol 2005, 34(2):333-343.
4. Moreno C., Laje G., Blanco C., Jiang H., Schmidt A.B., Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007, 64(9):1032-1039.
5. Healy D. The latest mania: selling bipolar disorder. PLoS Med 2006, 3(4):e185.
6. Leibenluft E., Charney D.S., Towbin K.E., Bhangoo R.K., Pine D.S. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003, 160(3):430-437.
7. Dickstein D.P., Towbin K.E., Van Der Veen J.W., Rich B.A., Brotman M.A., Knopf L., et al. Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol 2009, 19(1):61-73.
8. Masi G., Perugi G., Millepiedi S., Mucci M., Toni C., Bertini N., et al. Developmental differences according to age at onset in juvenile bipolar disorder. J Child Adolesc Psychopharmacol 2006, 16(6):679-685.
9. Waxmonsky J., Pelham W.E., Gnagy E., Cummings M.R., O'Connor B., Majumdar A., et al. The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol 2008, 18(6):573-588.
10. Brotman M.A., Kassem L., Reising M.M., Guyer A.E., Dickstein D.P., Rich B.A., et al. Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. Am J Psychiatry 2007, 164(8):1238-1241.
11. Stringaris A., Cohen P., Pine D.S., Leibenluft E. Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry 2009, 166(9):1048-1054.
12. Kowatch R.A., Fristad M., Birmaher B., Wagner K.D., Findling R.L., Hellander M. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005, 44(3):213-235.
13. McClellan J. Commentary: treatment guidelines for child and adolescent bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005, 44(3):236-239.
14. Consoli A., Deniau E., Huynh C., Purper D., Cohen D. Treatments in child and adolescent bipolar disorders. Eur Child Adolesc Psychiatry 2007, 16(3):187-198.
15. Consoli A., Bouzamondo A., Guile J.M., Lechat P., Cohen D. Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a meta-analysis. Can J Psychiatry 2007, 52(5):323-328.
16. Marcelli D., Cohen D. Enfance et psychopathologie 2009, Masson, Paris.
17. Geller B., Cooper T.B., Sun K., Zimerman B., Frazier J., Williams M., et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998, 37(2):171-178.
18. Kafantaris V., Coletti D.J., Dicker R., Padula G., Pleak R.R., Alvir J.M. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2004, 43(8):984-993.
19. Wagner K.D., Redden L., Kowatch R.A., Wilens T.E., Segal S., Chang K., et al. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 2009, 48(5):519-532.
20. DelBello M.P., Kowatch R.A., Adler C.M., Stanford K.E., Welge J.A., Barzman D.H., et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006, 45(3):305-313.
21. Pavuluri M.N., Henry D.B., Findling R.L., Parnes S., Carbray J.A., Mohammed T., et al. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord 2010, 12(6):593-605.
22. Delbello M.P., Schwiers M.L., Rosenberg H.L., Strakowski S.M. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002, 41(10):1216-1223.
23. Wagner K.D., Kowatch R.A., Emslie G.J., Findling R.L., Wilens T.E., McCague K., et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006, 163(7):1179-1186.
24. Tramontina S., Zeni C.P., Ketzer C.R., Pheula G.F., Narvaez J., Rohde L.A. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry 2009, 70(5):756-764.
25. Tohen M., Kryzhanovskaya L., Carlson G., Delbello M., Wozniak J., Kowatch R., et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007, 164(10):1547-1556.
26. Findling R.L., Nyilas M., Forbes R.A., McQuade R.D., Jin N., Iwamoto T., et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2009, 70(10):1441-1451.
27. DelBello M.P., Chang K., Welge J.A., Adler C.M., Rana M., Howe M., et al. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 2009, 11(5):483-493.
28. Haas M., Delbello M.P., Pandina G., Kushner S., Van Hove I., Augustyns I., et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2009, 11(7):687-700.
29. Findling R.L., McNamara N.K., Youngstrom E.A., Stansbrey R., Gracious B.L., Reed M.D., et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005, 44(5):409-417.
30. Henry C.A., Zamvil L.S., Lam C., Rosenquist K.J., Ghaemi S.N. Long-term outcome with divalproex in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2003, 13(4):523-529.
31. Strober M., Morrell W., Lampert C., Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990, 147(4):457-461.
32. Strober M., Schmidt-Lackner S., Freeman R., Bower S., Lampert C., DeAntonio M. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995, 34(6):724-731.
33. Dailey L.F., Townsend S.W., Dysken M.W., Kuskowski M.A. Recidivism in medication-noncompliant serious juvenile offenders with bipolar disorder. J Clin Psychiatry 2005, 66(4):477-484.
34. Drotar D., Greenley R.N., Demeter C.A., McNamara N.K., Stansbrey R.J., Calabrese J.R., et al. Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007, 46(7):831-839.
35. DelBello M.P., Hanseman D., Adler C.M., Fleck D.E., Strakowski S.M. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007, 164(4):582-590.
36. Patel N.C., DelBello M.P., Keck P.E., Strakowski S.M. Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2005, 15(6):938-946.
37. Malone R.P., Delaney M.A., Luebbert J.F., White M.A., Biesecker K.A., Cooper T.B. The lithium test dose prediction method in aggressive children. Psychopharmacol Bull 1995, 31(2):379-382.
38. Geller B., Luby J. Child and adolescent bipolar disorder: a review of the past 10years. J Am Acad Child Adolesc Psychiatry 1997, 36(9):1168-1176.
39. Silva R.R., Campbell M., Golden R.R., Small A.M., Pataki C.S., Rosenberg C.R. Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacol Bull 1992, 28(3):319-326.
40. Hagino O.R., Weller E.B., Weller R.A., Washing D., Fristad M.A., Kontras S.B. Untoward effects of lithium treatment in children aged four through six years. J Am Acad Child Adolesc Psychiatry 1995, 34(12):1584-1590.
41. Ryan N.D., Bhatara V.S., Perel J.M. Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38(5):529-536.
42. Isojarvi J.I., Laatikainen T.J., Pakarinen A.J., Juntunen K.T., Myllyla V.V. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993, 329(19):1383-1388.
43. Kowatch R.A., DelBello M.P. Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr Clin North Am 2005, 28(2):385-397.
44. Correll C.U. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 2007, 46(6):687-700.
45. Kowatch R.A., DelBello M.P. The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders. CNS Spectr 2003, 8(4):273-280.
46. Kowatch R.A., Sethuraman G., Hume J.H., Kromelis M., Weinberg W.A. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003, 53(11):978-984.
47. Bhangoo R.K., Lowe C.H., Myers F.S., Treland J., Curran J., Towbin K.E., et al. Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 2003, 13(4):515-522.
48. Sevilla-Dedieu C., Kovess-Masfety V. Psychotropic medication use in children and adolescents: a study from France. J Child Adolesc Psychopharmacol 2008, 18(3):281-289.
49. Consoli A., Brunelle J., Bodeau N., Perisse D., Deniau E., Guile J.M., et al. Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode. J Can Acad Child Adolesc Psychiatry 2009, 18(3):231-238.